Suppr超能文献

血液透析患者载脂蛋白、氧化高密度脂蛋白与心血管事件之间的关联

Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.

作者信息

Honda Hirokazu, Hirano Tsutomu, Ueda Masashi, Kojima Shiho, Mashiba Shinichi, Hayase Yasuyuki, Michihata Tetsuo, Shishido Kanji, Takahashi Keiko, Hosaka Nozomu, Ikeda Misa, Sanada Daisuke, Shibata Takanori

机构信息

Division of Nephrology, Department of Medicine, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

出版信息

PLoS One. 2017 May 18;12(5):e0177980. doi: 10.1371/journal.pone.0177980. eCollection 2017.

Abstract

Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL, mortality and cardiovascular disease (CVD) events in patients on HD. This prospective observational study examined 412 patients on prevalent HD. Blood samples were obtained before dialysis at baseline to measure lipids, apolipoproteins, oxidized LDL, oxidized HDL, high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 at baseline, and HDL-C and hs-CRP were measured 12 months later. Patients were then prospectively followed-up (mean, 40 months) and all-cause mortality and composite CVD events were analyzed. Associations between variables at baseline and clinical outcome were assessed by Cox proportional hazards modeling (n = 412) and Cox hazards modeling with a time-varying covariate with HDL-C and hs-CRP (n = 369). Quartiles of apolipoproteins and oxidized HDL were not associated with all-cause mortality. However, Cox proportional hazards models with quartiles of each variable adjusted for confounders and hs-CRP or IL-6 identified apolipoprotein (apo)B-to-apoA-I ratio (apoB/apoA-I) and oxidized HDL, but not apoA-I or apoA-II, as independent risk factors for composite CVD events. These associations were confirmed by Cox proportional hazards modeling with time-varying covariates for hs-CRP. ApoB/apoA-I was independently associated with composite CVD events in 1-standard deviation (SD) increase-of-variables models adjusted for the confounders, oxidized HDL and hs-CRP. However, these associations disappeared from the model adjusted with IL-6 instead of hs-CRP, and oxidized HDL and IL-6 were independently associated with composite CVD events. Findings resembled those from Cox proportional hazards modeling using time-varying covariates with HDL-C adjusted with IL-6. In conclusion, both oxidized HDL and apoB/apoA-I might be associated with CVD events in patients on prevalent HD, while associations of apoB/apoA-I with CVD events differed between models of apoB/apoA-I quartiles and 1-SD increases, and were influenced by IL-6.

摘要

载脂蛋白与血液透析(HD)患者的生存情况相关,但这些关联可能会受到功能失调(氧化)的高密度脂蛋白(HDL)的影响。我们评估了HD患者中载脂蛋白与氧化HDL、死亡率和心血管疾病(CVD)事件之间的关联。这项前瞻性观察性研究对412例接受HD治疗的患者进行了检查。在基线透析前采集血样,以测量基线时的血脂、载脂蛋白、氧化低密度脂蛋白、氧化HDL、高敏C反应蛋白(hs-CRP)和白细胞介素(IL)-6,并在12个月后测量HDL-C和hs-CRP。然后对患者进行前瞻性随访(平均40个月),并分析全因死亡率和复合CVD事件。通过Cox比例风险模型(n = 412)以及使用HDL-C和hs-CRP作为时变协变量的Cox风险模型(n = 369)评估基线变量与临床结局之间的关联。载脂蛋白和氧化HDL的四分位数与全因死亡率无关。然而,在对混杂因素以及hs-CRP或IL-6进行调整的每个变量四分位数的Cox比例风险模型中,载脂蛋白(apo)B与apoA-I的比值(apoB/apoA-I)和氧化HDL被确定为复合CVD事件的独立危险因素,而apoA-I或apoA-II则不是。通过使用hs-CRP的时变协变量的Cox比例风险模型证实了这些关联。在针对混杂因素、氧化HDL和hs-CRP进行调整的1标准差(SD)变量增加模型中,apoB/apoA-I与复合CVD事件独立相关。然而,在用IL-6而非hs-CRP进行调整的模型中,这些关联消失了,并且氧化HDL和IL-6与复合CVD事件独立相关。研究结果与使用经IL-6调整的HDL-C作为时变协变量的Cox比例风险模型的结果相似。总之,氧化HDL和apoB/apoA-I可能都与接受HD治疗的患者的CVD事件相关,而apoB/apoA-I与CVD事件的关联在apoB/apoA-I四分位数模型和1-SD增加模型之间有所不同,并且受到IL-6的影响。

相似文献

1
Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
PLoS One. 2017 May 18;12(5):e0177980. doi: 10.1371/journal.pone.0177980. eCollection 2017.
2
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Atherosclerosis. 2012 Feb;220(2):493-501. doi: 10.1016/j.atherosclerosis.2011.10.038. Epub 2011 Nov 3.
4
Truncal Adiposity Influences High-Density Lipoprotein Cholesterol Levels and Cardiovascular Events in Hemodialysis Patients.
J Ren Nutr. 2019 May;29(3):235-242. doi: 10.1053/j.jrn.2018.08.011. Epub 2018 Oct 12.
5
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Circulation. 2019 Aug 13;140(7):542-552. doi: 10.1161/CIRCULATIONAHA.119.041149. Epub 2019 Jun 20.
8
Apoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.
Clin J Am Soc Nephrol. 2016 May 6;11(5):840-846. doi: 10.2215/CJN.09830915. Epub 2016 Feb 15.

引用本文的文献

1
High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p.
Sci China Life Sci. 2024 Feb;67(2):286-300. doi: 10.1007/s11427-022-2381-7. Epub 2023 Oct 25.
2
The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis.
Acta Pharmacol Sin. 2022 May;43(5):1167-1179. doi: 10.1038/s41401-021-00819-w. Epub 2021 Dec 10.
3
Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.
Pediatr Nephrol. 2021 Aug;36(8):2537-2544. doi: 10.1007/s00467-021-05102-y. Epub 2021 Jun 18.
5
Cardiovascular risk factors in children on dialysis: an update.
Pediatr Nephrol. 2020 Jan;35(1):41-57. doi: 10.1007/s00467-018-4125-x. Epub 2018 Oct 31.
6
ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients?
Semin Dial. 2018 Jul;31(4):398-405. doi: 10.1111/sdi.12706. Epub 2018 Apr 29.
8
Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus.
J Thromb Thrombolysis. 2018 Feb;45(2):200-205. doi: 10.1007/s11239-017-1594-x.

本文引用的文献

1
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1163-1172. doi: 10.2215/CJN.10441015. Epub 2016 Jun 8.
2
Apoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.
Clin J Am Soc Nephrol. 2016 May 6;11(5):840-846. doi: 10.2215/CJN.09830915. Epub 2016 Feb 15.
5
Enzymatic antioxidant system in vascular inflammation and coronary artery disease.
World J Exp Med. 2015 Nov 20;5(4):218-24. doi: 10.5493/wjem.v5.i4.218.
6
High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
J Atheroscler Thromb. 2016;23(1):81-94. doi: 10.5551/jat.30015. Epub 2015 Aug 18.
7
Acrolein impairs the cholesterol transport functions of high density lipoproteins.
PLoS One. 2015 Apr 7;10(4):e0123138. doi: 10.1371/journal.pone.0123138. eCollection 2015.
8
Paraoxonase 1 and HDL maturation.
Clin Chim Acta. 2015 Jan 15;439:5-13. doi: 10.1016/j.cca.2014.09.016. Epub 2014 Sep 28.
9
HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.
J Am Soc Nephrol. 2015 Feb;26(2):484-92. doi: 10.1681/ASN.2013080816. Epub 2014 Jul 10.
10
An abundant dysfunctional apolipoprotein A1 in human atheroma.
Nat Med. 2014 Feb;20(2):193-203. doi: 10.1038/nm.3459. Epub 2014 Jan 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验